This inventor holds 1 USPTO granted patent. Top assignee: Carnegie Mellon University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Juha-Pekka Mattila
Introduction
Juha-Pekka Mattila is an accomplished inventor based in Pearland, TX (US). He has made significant contributions to the field of molecular biology through his innovative inventions. His work focuses on the detection and quantification of immunological proteins, pathogenic and microbial agents, and cells.
Latest Patents
Juha-Pekka Mattila holds a patent for "Devices and methods for detection and quantification of immunological proteins, pathogenic and microbial agents and cells." This invention provides microfluidic pScreen™ devices that quantify the concentration of DNA fragments in a liquid sample. The devices utilize magnetic-responsive silica micro-beads and nonmagnetic-responsive silica micro-beads. They allow for rapid, simple, and inexpensive quantification of DNA fragment concentration in a sample. The devices do not require complex instrumentation and can be performed in less than three minutes. Moreover, they are compatible with complex samples, including unpurified PCR amplification products, and can seamlessly integrate into various common molecular biology techniques and workflows. Juha-Pekka Mattila has 1 patent to his name.
Career Highlights
Juha-Pekka Mattila is affiliated with Carnegie Mellon University, where he continues to advance his research and innovations. His work has garnered attention for its practical applications in the field of molecular biology.
Collaborations
Some of his notable coworkers include Alberto Gandini and James F Antaki. Their collaborative efforts contribute to the advancement of research and innovation in their respective fields.
Conclusion
Juha-Pekka Mattila's contributions to the field of molecular biology through his innovative patent demonstrate his commitment to advancing scientific knowledge and practical applications. His work continues to impact the way researchers quantify DNA fragments, making significant strides in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
